SCHEMBL29566900

SCHEMBL29566900

Cc1ccccc1Oc1nc(NS(=O)(=O)c2cnn(C)c2)nc(-c2ccccc2C)c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 7/20 0.43
▸ HTR7 P34969 7/20 0.43
▸ DRD2 P14416 3/20 0.37
▸ HTR6 P50406 1/20 0.37
▸ THRB P10828 1/20 0.36
▸ HTR2A P28223 2/20 0.35
▸ KMT2A Q03164 2/20 0.34
▸ RXFP1 Q9HBX9 1/20 0.34
▸ PIK3CD O00329 1/20 0.34
▸ PIK3CB P42338 1/20 0.34
▸ MTOR P42345 1/20 0.34
▸ PIK3CG P48736 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ SCN9A Q15858 2/20 0.34
▸ PCK1 P35558 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ HPGD P15428 1/20 0.33
▸ BRAF P15056 1/20 0.33
▸ SLC22A12 Q96S37 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309827 1.00 HTR1A (0.43) HTR1AHTR7DRD2HTR6THRB
SCHEMBL24309861 0.91 HTR1A (0.40) HTR1AHTR7DRD2HTR2AKMT2A
SCHEMBL29567228 0.91 HTR1A (0.40) HTR1AHTR7DRD2HTR2AKMT2A
SCHEMBL29566904 0.90 HTR1A (0.42) HTR1AHTR7DRD2HTR6THRB
SCHEMBL24309396 0.90 HTR1A (0.42) HTR1AHTR7DRD2HTR6THRB
SCHEMBL29567189 0.90 HTR1A (0.42) HTR1AHTR7DRD2HTR6THRB
SCHEMBL24309825 0.90 HTR1A (0.42) HTR1AHTR7DRD2HTR6THRB
SCHEMBL24309877 0.90 HTR1A (0.42) HTR1AHTR7DRD2HTR6THRB
SCHEMBL24310178 0.90 HTR1A (0.42) HTR1AHTR7DRD2HTR6THRB
SCHEMBL29567180 0.90 HTR1A (0.42) HTR1AHTR7DRD2HTR6THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback